生物製药分析测试服务市场规模、份额、成长分析、按分子类型、按测试类型、按工作流程、按应用、按最终用户、按地区 - 行业预测，2024-2031 年

2022年生物製药分析测试服务的全球市场规模为29亿美元，从2023年的33.5亿美元增长到2031年的106.9亿美元，在预测期内（2024-2031年）预计将以复合年增长率增长。

在生物製药领域，成功的药物开发取决于先进分析技术支援的蛋白质和化合物的准确分类。这些技术对于理解生物製药的结构和功能至关重要，为从候选药物选择到製程优化的每个步骤提供资讯。为了因应不断发展的研究和开发环境，对多样化分析工具的需求正在迅速增加。儘管北美的分析测试服务最初因 COVID-19 大流行而关闭和中断，但限制正在逐渐取消，实验室运作正在恢復。随着生命科学服务的恢復，生物製药分析测试服务的需求预计将增加，从而推动该地区在预测期内的市场成长。

目录

介绍

• 研究目的
• 调查范围
• 定义

调查方法

• 资讯采购
• 二手资料和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 抑制因素和挑战
• 波特分析与影响
  • 竞争公司之间的敌对关係
  • 替代品的威胁
  • 买方议价能力
  • 新进入者的威胁
  • 供应商的议价能力

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2023）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 价格分析
• 监管环境
• 专利分析

按分子类型和复合年增长率分類的生物製药分析测试服务市场规模（2024-2031）

• 市场概况
• 小分子
• 高分子

生物製药分析测试服务市场规模：依测试类型和复合年增长率（2024-2031）

• 市场概况
• ADME（吸收分布代谢排泄）
• 药物动力学（PK）
• 动态（PD）
• 生物有效性
• 生物等效性
• 其他的

生物製药分析测试服务市场规模：依工作流程及复合年增长率（2024-2031）

• 市场概况
• 样品製备
• 样品分析

生物製药分析测试服务市场规模：按应用和复合年增长率（2024-2031）

• 市场概况
• 肿瘤学
• 神经病学
• 心臟病学
• 感染疾病
• 其他的

按最终用户分類的生物製药分析测试服务市场规模和复合年增长率（2024-2031）

• 市场概况
• 製药和生物技术公司
• 合约研究组织（CRO）
• 学术研究所
• 其他的

生物製药分析测试服务市场规模及复合年增长率（2024-2031）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 英国
  • 德国
  • 西班牙
  • 法国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东/非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争资讯

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2023）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分類的份额分析
  • 收益与前一年同期比较（2021-2023）

主要企业简介

• Eurofins Scientific
• Charles River Laboratories
• WuXi AppTec
• SGS SA
• Laboratory Corporation of America Holdings（LabCorp）
• IQVIA
• Medpace
• Intertek Group
• Syneos Health
• ICON plc
• Frontage Laboratories
• PPD（Pharmaceutical Product Development）
• PAREXEL International
• Almac Group
• Celerion
• Altasciences
• BioAgilytix Labs
• Lotus Labs
• LGS Limited
• Sartorius AG

结论和建议

Global Biopharmaceutical Analytical Testing Services Market size was valued at USD 2.90 billion in 2022 and is poised to grow from USD 3.35 billion in 2023 to USD 10.69 billion by 2031, growing at a CAGR of 15.6% during the forecast period (2024-2031).

In the biopharmaceutical sector, successful drug development hinges on the precise classification of proteins and compounds, supported by advanced analytical methods. These technologies are essential for comprehending the structure and functionality of biotherapeutics, informing every stage from drug candidate selection to process optimization. The demand for diverse analytical tools is surging in response to the evolving R&D landscape. Although the COVID-19 pandemic initially hindered analytical testing services in North America due to lockdowns, the gradual lifting of restrictions has rejuvenated laboratory operations. As life sciences services resume, there is an anticipated increase in demand for biopharmaceutical analytical testing services, propelling market growth in the region throughout the forecasted period.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Biopharmaceutical Analytical Testing Services market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Biopharmaceutical Analytical Testing Services Market Segmental Analysis

Global Biopharmaceutical Analytical Testing Services Market is segmented by molecule type, test type, workflow, application, end user and region. Based on molecule type, the market is segmented into small molecule and large molecule. Based on test type, the market is segmented into ADME (absorption, distribution, metabolism, and excretion), pharmacokinetics (PK), pharmacodynamics (PD), bioavailability, bioequivalence and others. Based on workflow, the market is segmented into sample preparation and sample analysis. Based on application, the market is segmented into oncology, neurology, cardiology, infectious diseases and others. Based on end users, the market is segmented into pharmaceutical and biotechnology companies, contract research organizations (CROs), academic and research institutes and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Biopharmaceutical Analytical Testing Services Market

A significant driver of growth in the global biopharmaceutical analytical testing services market is the escalating demand for Methyl Methacrylate Acrylonitrile Butadiene Styrene, primarily used in immunotherapy to enhance immune responses against various diseases. Research and development initiatives focused on antibodies for conditions such as rheumatoid arthritis and cancer are expanding. Targeted treatments for cancer involve specific localization to improve efficacy. Additionally, the rising preference for customized medicine is boosting the need for monoclonal antibodies, prompting pharmaceutical and biotechnology companies to manufacture Ethyl Methacrylate Acrylonitrile. Consequently, these products undergo rigorous quality control processes, including microbial, sterility, and dissolution testing, to ensure drug integrity, which subsequently fuels the demand for biopharmaceutical analytical testing services that provide critical impurity data, characterization, and validation.

Restraints in the Global Biopharmaceutical Analytical Testing Services Market

Global Biopharmaceutical Analytical Testing Services face several restraints that can impact their operations and growth. Stringent regulatory requirements necessitate rigorous compliance, potentially delaying product testing and market entry. The rapidly evolving technological landscape demands continuous investment in advanced analytical methods, which can strain financial resources. Additionally, the shortage of skilled professionals in the biopharmaceutical field can hinder the capacity to meet increasing demand for testing services. Competition among service providers leads to price pressures, while the complexity of biologics requires specialized expertise that may not be universally available, limiting the ability to scale operations efficiently within a global framework.

Market Trends of the Global Biopharmaceutical Analytical Testing Services Market

The Global Biopharmaceutical Analytical Testing Services market is witnessing a significant upward trend, fueled by heightened investments in research and development (R&D). With R&D expenditures surging by 3.21% in 2021, the focus on enhancing analytical testing capabilities is set to intensify. Emerging economies are outpacing their developed counterparts, showcasing robust growth through the establishment of new laboratories and research facilities. This shift not only fosters innovation but also enhances the overall capacity for biopharmaceutical testing, meeting the increasing demand for high-quality and efficient biotherapeutic solutions. As a result, the market is poised for substantial expansion in the coming years.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Patent Analysis

Global Biopharmaceutical Analytical Testing Services Market Size by Molecule Type & CAGR (2024-2031)

• Market Overview
• Small Molecule
• Large Molecule

Global Biopharmaceutical Analytical Testing Services Market Size by Test Type & CAGR (2024-2031)

• Market Overview
• ADME (Absorption, Distribution, Metabolism, and Excretion)
• Pharmacokinetics (PK)
• Pharmacodynamics (PD)
• Bioavailability
• Bioequivalence
• Others

Global Biopharmaceutical Analytical Testing Services Market Size by Workflow & CAGR (2024-2031)

• Market Overview
• Sample Preparation
• Sample Analysis

Global Biopharmaceutical Analytical Testing Services Market Size by Application & CAGR (2024-2031)

• Market Overview
• Oncology
• Neurology
• Cardiology
• Infectious Diseases
• Others

Global Biopharmaceutical Analytical Testing Services Market Size by End User & CAGR (2024-2031)

• Market Overview
• Pharmaceutical and Biotechnology Companies
• Contract Research Organizations (CROs)
• Academic and Research Institutes
• Others

Global Biopharmaceutical Analytical Testing Services Market Size & CAGR (2024-2031)

• North America (Molecule Type, Test Type, Workflow, Application, End User)
  • US
  • Canada
• Europe (Molecule Type, Test Type, Workflow, Application, End User)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific (Molecule Type, Test Type, Workflow, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America (Molecule Type, Test Type, Workflow, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Molecule Type, Test Type, Workflow, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Eurofins Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Charles River Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WuXi AppTec
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SGS SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Laboratory Corporation of America Holdings (LabCorp)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IQVIA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medpace
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Intertek Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Syneos Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ICON plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Frontage Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PPD (Pharmaceutical Product Development)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PAREXEL International
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Almac Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Celerion
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Altasciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioAgilytix Labs
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lotus Labs
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LGS Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sartorius AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation